Swiss drugmaker Roche is poised to get back into antibiotics by taking over a candidate drug being developed by privately-owned Polyphor, the NZZ am Sonntag paper said on Sunday, without citing a source for the information. Roche's Chief Executive Severin Schwan said last month that the company was interested in "bolt-on acquisitions". But a company spokesman declined to confirm the report on Sunday, saying the firm did not comment on rumors. "We have an open and pragmatic approach to R&D and have mentioned in the past that antibiotics is an area where a lot of interesting science is going on," Roche spokesman Daniel Grotzky said in an emailed reply to a Reuters enquiry.
via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment